BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schuler LA, Murdoch FE. Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers. Cancers (Basel) 2021;13:3725. [PMID: 34359625 DOI: 10.3390/cancers13153725] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ahn S, Kwon A, Huh YH, Rhee S, Song WK. Tumor-derived miR-130b-3p induces cancer-associated fibroblast activation by targeting SPIN90 in luminal A breast cancer. Oncogenesis 2022;11:47. [PMID: 35948548 DOI: 10.1038/s41389-022-00422-6] [Reference Citation Analysis]
2 Vathiotis IA, Trontzas I, Gavrielatou N, Gomatou G, Syrigos NK, Kotteas EA. Immune Checkpoint Blockade in Hormone Receptor-Positive Breast Cancer: Resistance Mechanisms and Future Perspectives. Clin Breast Cancer 2022:S1526-8209(22)00140-9. [PMID: 35906130 DOI: 10.1016/j.clbc.2022.06.004] [Reference Citation Analysis]
3 Schuler LA, O’leary KA. Prolactin: The Third Hormone in Breast Cancer. Front Endocrinol 2022;13:910978. [DOI: 10.3389/fendo.2022.910978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Northey JJ, Weaver VM. Mechanosensitive steroid hormone signaling and cell fate. Endocrinology 2022:bqac085. [PMID: 35678467 DOI: 10.1210/endocr/bqac085] [Reference Citation Analysis]